January 25, 2017
Takara Bio has submitted a clinical trial plan to the Pharmaceuticals and Medical Devices Agency (PMDA) in preparation for a PI/II trial to evaluate the efficacy and safety of siTCR gene therapy in patients with synovial sarcoma, the company announced...read more